通过专为投资者打造的一站式数据看板，全面查看 Theravance Biopharma Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

882.66M

股息TTM

0.00

市盈率 TTM

7.47

每股收益TTM

2.28

营业收入

107.46M

净利润

-56.42M

净资产收益率

50.17%

总资产收益率

28.08%

Theravance Biopharma Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-110.45%-0.11

64.79%-0.10

481.13%1.20

127.64%0.07

422.29%1.09

-13.08%-0.27

-82.57%-0.31

-51.49%-0.26

-22.85%-0.34

31.17%-0.24

-12.05%-0.17

---0.17

---0.28

---0.35

---0.15

--11.66

----

营业收入

-20.86%20.73M

15.02%17.70M

144.70%45.89M

18.51%19.99M

83.75%26.20M

6.10%15.39M

6.77%18.75M

7.49%16.87M

3.69%14.26M

39.22%14.50M

19.91%17.57M

26.04%15.69M

24.43%13.75M

-21.06%10.42M

-1.99%14.65M

-5.63%12.45M

-14.43%11.05M

-7.44%13.20M

-20.20%14.95M

-27.73%13.19M

净利润

-110.76%-5.90M

63.67%-4.93M

493.02%61.02M

128.47%3.62M

431.75%54.84M

-16.42%-13.58M

-82.46%-15.53M

-41.88%-12.70M

-5.65%-16.53M

47.19%-11.66M

17.87%-8.51M

-100.98%-8.95M

-91.00%-15.64M

14.87%-22.09M

67.65%-10.36M

2696.10%916.63M

84.37%-8.19M

67.44%-25.95M

45.18%-32.03M

52.06%-35.31M

利润率

-113.59%-28.45%

68.42%-27.87%

260.61%132.98%

124.02%18.08%

280.55%209.33%

-9.72%-88.24%

-70.89%-82.79%

-31.99%-75.28%

-1.89%-115.94%

62.07%-80.42%

50.22%-48.45%

---57.03%

---113.79%

---212.04%

---97.32%

---214.10%

----

毛利率

0.00%100.00%

--100.00%

----

资产负债率

-6.00%6.98%

-22.99%6.94%

-21.15%6.75%

-7.01%7.75%

-7.48%7.43%

17.81%9.02%

17.74%8.57%

26.94%8.34%

35.01%8.03%

58.60%7.65%

73.69%7.27%

--6.57%

--5.95%

--4.83%

--4.19%

--3.26%

----

利润表

营业收入

-20.86%20.73M

15.02%17.70M

144.70%45.89M

18.51%19.99M

83.75%26.20M

6.10%15.39M

6.77%18.75M

7.49%16.87M

3.69%14.26M

39.22%14.50M

19.91%17.57M

26.04%15.69M

24.43%13.75M

-21.06%10.42M

-1.99%14.65M

-5.63%12.45M

-14.43%11.05M

-7.44%13.20M

-20.20%14.95M

-27.73%13.19M

营业利润

167.63%1.84M

59.47%-5.85M

317.51%20.01M

30.40%-6.46M

78.63%-2.73M

-28.79%-14.43M

-47.44%-9.20M

-5.88%-9.28M

14.71%-12.75M

51.98%-11.21M

61.05%-6.24M

36.03%-8.76M

25.59%-14.95M

16.35%-23.34M

57.61%-16.02M

73.59%-13.69M

68.65%-20.10M

66.74%-27.90M

50.50%-37.80M

32.33%-51.84M

净利润

-110.76%-5.90M

63.67%-4.93M

493.02%61.02M

128.47%3.62M

431.75%54.84M

-16.42%-13.58M

-82.46%-15.53M

-41.88%-12.70M

-5.65%-16.53M

47.19%-11.66M

17.87%-8.51M

-100.98%-8.95M

-91.00%-15.64M

14.87%-22.09M

67.65%-10.36M

2696.10%916.63M

84.37%-8.19M

67.44%-25.95M

45.18%-32.03M

52.06%-35.31M

资产负债表

流动资产

13.75%416.66M

177.93%417.63M

159.80%418.46M

204.51%354.70M

207.02%366.29M

20.89%150.26M

20.61%161.07M

-27.96%116.48M

-37.86%119.31M

-52.44%124.29M

-62.22%133.54M

-68.40%161.69M

24.09%192.00M

27.71%261.34M

41.46%353.46M

72.20%511.72M

-53.56%154.73M

-30.18%204.64M

-36.47%249.87M

-34.07%297.17M

流动负债总额

-43.69%30.77M

0.87%31.77M

19.38%38.30M

59.62%37.41M

138.09%54.63M

45.43%31.50M

29.55%32.09M

-7.62%23.43M

-6.52%22.95M

-17.27%21.66M

-13.75%24.77M

-82.15%25.37M

-24.76%24.55M

-40.76%26.18M

-50.99%28.71M

115.08%142.13M

-51.40%32.62M

-48.90%44.20M

-52.59%58.59M

-36.62%66.08M

总资产

10.27%469.77M

37.47%472.31M

37.10%485.57M

16.67%415.46M

17.68%426.04M

-7.47%343.58M

-7.29%354.16M

-13.90%356.11M

-18.94%362.03M

-31.05%371.31M

-37.11%382.00M

-45.83%413.59M

23.80%446.63M

51.55%538.55M

62.05%607.40M

89.40%763.50M

-15.96%360.76M

-5.26%355.36M

-20.09%374.82M

-21.30%403.11M

总负债

-10.50%180.06M

2.32%181.72M

5.73%188.85M

7.23%182.78M

19.51%201.19M

6.71%177.60M

5.69%178.62M

1.79%170.45M

1.12%168.34M

-0.92%166.44M

2.06%169.00M

-40.81%167.46M

-76.57%166.47M

-76.23%167.99M

-76.79%165.60M

-61.07%282.92M

-2.61%710.57M

-5.55%706.81M

-7.69%713.39M

-6.08%726.70M

总权益

28.84%289.70M

75.07%290.59M

69.03%296.72M

25.33%232.68M

16.09%224.85M

-18.98%165.98M

-17.58%175.54M

-24.57%185.65M

-30.87%193.69M

-44.71%204.87M

-51.79%213.00M

-48.78%246.13M

180.09%280.16M

205.44%370.56M

230.49%441.80M

248.51%480.58M

-16.46%-349.81M

5.83%-351.45M

-11.46%-338.57M

-23.73%-323.59M

现金流量表

经营净额

-103.35%-6.96M

70.26%73.28M

-572.28%-6.06M

-25.25%-6.51M

4812.89%208.07M

4311.25%43.04M

-5.62%-902.00K

-109.01%-5.20M

64.50%-4.42M

90.89%-1.02M

-101.56%-854.00K

84.97%-2.49M

15.57%-12.44M

56.96%-11.22M

229.41%54.91M

63.61%-16.54M

70.61%-14.73M

62.69%-26.07M

34.64%-42.43M

41.00%-45.45M

投资净额

-66.59%-60.40M

71.69%52.59M

-96.25%588.00K

-476.16%-100.25M

-1096.24%-36.26M

79.89%30.63M

2416.99%15.69M

-82752.38%-17.40M

-127.44%-3.03M

139.56%17.03M

-101.73%-677.00K

99.89%-21.00K

47.00%11.05M

-234.84%-43.05M

261.80%39.16M

44.89%-19.73M

-78.99%7.51M

-71.92%31.92M

-79.33%10.82M

-153.79%-35.79M

融资净额

-92.25%-967.00K

-553.04%-5.58M

-308.49%-1.49M

-7.53%-400.00K

-1043.18%-503.00K

50.23%-854.00K

98.81%-365.00K

98.82%-372.00K

99.95%-44.00K

96.95%-1.72M

13.71%-30.61M

95.53%-31.40M

-57728.57%-80.68M

-3783.98%-56.24M

-23906.71%-35.47M

-30601.53%-701.84M

-99.87%140.00K

87.17%-1.45M

-79.95%149.00K

-137.38%-2.29M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Theravance Biopharma Inc的总收入是多少？



根据Theravance Biopharma Inc的FY2025财报，总收入达到了107.46M（同比变化64.38M）。

Theravance Biopharma Inc的流动资产是多少？



根据Theravance Biopharma Inc的FY2025财报，流动资产为418.46M（同比变化159.80）。

Theravance Biopharma Inc的总资产是多少？



根据Theravance Biopharma Inc的FY2025财报，Theravance Biopharma Inc的总资产为485.57M（同比变化37.10）。

Theravance Biopharma Inc的总负债是多少？



根据Theravance Biopharma Inc的FY2025财报，Theravance Biopharma Inc的总负债为188.85M（同比变化5.73）。

Theravance Biopharma Inc的总权益是多少？



根据Theravance Biopharma Inc的FY2025财报，Theravance Biopharma Inc的总权益为296.72M（同比变化69.03）。

Theravance Biopharma Inc的净营业收入是多少？



根据Theravance Biopharma Inc的FY2025财报，Theravance Biopharma Inc的净营业收入为-3.60M（同比变化91.51）。

Theravance Biopharma Inc的净投资是多少？



根据Theravance Biopharma Inc的FY2025财报，Theravance Biopharma Inc的净投资为-105.28M（同比变化-957.08）。

Theravance Biopharma Inc的净融资是多少？



根据Theravance Biopharma Inc的FY2025财报，Theravance Biopharma Inc的净融资为-3.25M（同比变化-30.08）。

Theravance Biopharma Inc的每股收益（EPS）是多少？



根据Theravance Biopharma Inc的FY2025财报，每股收益（EPS）为2.10（同比变化282.21）。

Theravance Biopharma Inc的净利润是多少？



根据Theravance Biopharma Inc的FY2025财报，净利润为105.89M（同比变化287.70）。

Theravance Biopharma Inc的净利润率是多少？



根据Theravance Biopharma Inc的FY2025财报，净利润率为98.54（同比变化212.45）。

Theravance Biopharma Inc的债务与资产比率是多少？



根据Theravance Biopharma Inc的FY2025财报，债务与资产比率为6.75（同比变化-21.15）。

Theravance Biopharma Inc的股东权益回报率（ROE）是多少？



根据Theravance Biopharma Inc的FY2025财报，股东权益回报率（ROE）为44.85（同比变化254.42）。

Theravance Biopharma Inc的资产回报率（ROA）是多少？



根据Theravance Biopharma Inc的FY2025财报，资产回报率（ROA）为25.22（同比变化264.55）。

Theravance Biopharma Inc的营业利润是多少？



根据Theravance Biopharma Inc的FY2025财报，营业利润为-3.60M（同比变化91.51）。